abstract |
FIELD: medicine. n SUBSTANCE: what is described is a composition for topical application which contains a continuous phase and at least one disperse phase with said composition containing at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue. n EFFECT: composition is characterised by better skin penetration or better stability. n 27 cl, 3 dwg, 17 ex |